Timothy A. Yap

ASCO in Real Time: Breaking Advances for Nuclear Medicine

Abstract placeholder. Drop in the official SNMMI session abstract once published.

Day and time to be confirmed against the SNMMI program.

1. How do you separate signal from noise in imaging endpoints right now?
2. Where is the real money flowing in the CDMO build-out, and is it the right place?
3. What's the actual bottleneck right now, isotopes, hot cells, or trained technologists?

Generated by a mock model. Wired to Anthropic when the API key is in place.

What we're seeing

• FierceBiotech · 2026-03-02
  Timothy A Yap cited in NEJM perspective on theranostic standardization
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• BioPharma Reporter · 2026-04-25
  Timothy A Yap joins editorial board of European Journal of Nuclear Medicine
  The work builds on more than a decade of radiochemistry collaboration.
• Reuters Health · 2026-01-16
  Timothy A Yap presents updated trial data at ASCO Annual Meeting
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
• Endpoints News · 2026-10-11
  Timothy A Yap co-authors review on PSMA in Journal of Nuclear Medicine
  The work builds on more than a decade of radiochemistry collaboration.
• Nuclear Medicine Today · 2026-11-18
  Timothy A Yap comments on FDA guidance for radiopharmaceutical trials
  The announcement comes amid tightening Mo-99 and Lu-177 supply.

Mocked while we wire the Exa integration. Headlines are illustrative.